Analgesic use and renal function in men - PubMed (original) (raw)
. 2001 Jul 18;286(3):315-21.
doi: 10.1001/jama.286.3.315.
Affiliations
- PMID: 11466097
- DOI: 10.1001/jama.286.3.315
Analgesic use and renal function in men
K M Rexrode et al. JAMA. 2001.
Abstract
Context: Several case-control studies suggest an association between analgesic use and increased risk of chronic renal disease, but few cohort studies have examined this association.
Objective: To determine whether analgesic use is associated with risk of renal dysfunction.
Design and setting: Cohort study of analgesic use data from the Physicians' Health Study, which lasted 14 years from September 1982 to December 1995 with annual follow-up.
Participants: A total of 11 032 initially healthy men who provided blood samples and self-report of analgesic use.
Main outcome measures: Elevated creatinine level defined as 1.5 mg/dL (133 micromol/L) or higher and a reduced creatinine clearance defined as 55 mL/min (0.9 mL/s) or less, and self-reported use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs (never [<12 pills]; 12-1499 pills; 1500-2499 pills; and >/=2500 pills).
Results: A total of 460 men had elevated creatinine levels (4.2%) and 1258 had reduced creatinine clearance (11.4%). Mean creatinine levels and creatinine clearances were similar among men who did not use analgesics and those who did, even at total intakes of 2500 or more pills. In multivariable analyses adjusted for age; body mass index; history of hypertension, elevated cholesterol, and diabetes; occurrence of cardiovascular disease; physical activity; and use of other analgesics, the relative risks of elevated creatinine level associated with intake of 2500 or more pills were 0.83 (95% confidence interval [CI], 0.50-1.39; P for trend =.05) for acetaminophen, 0.98 (95% CI, 0.53-1.81; P for trend =.96) for aspirin, and 1.07 (95% CI, 0.71-1.64; P for trend =.86) for other nonsteroidal anti-inflammatory drugs. No association was observed between analgesic use and reduced creatinine clearance.
Conclusions: Moderate analgesic use in this cohort study of initially healthy men was not associated with increased risk of renal dysfunction.
Similar articles
- Analgesic use and change in kidney function in apparently healthy men.
Kurth T, Glynn RJ, Walker AM, Rexrode KM, Buring JE, Stampfer MJ, Hennekens CH, Gaziano JM. Kurth T, et al. Am J Kidney Dis. 2003 Aug;42(2):234-44. doi: 10.1016/s0272-6386(03)00647-4. Am J Kidney Dis. 2003. PMID: 12900803 - Analgesic use and risk of subsequent hypertension in apparently healthy men.
Kurth T, Hennekens CH, Stürmer T, Sesso HD, Glynn RJ, Buring JE, Gaziano JM. Kurth T, et al. Arch Intern Med. 2005 Sep 12;165(16):1903-9. doi: 10.1001/archinte.165.16.1903. Arch Intern Med. 2005. PMID: 16157836 - Lifetime nonnarcotic analgesic use and decline in renal function in women.
Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ. Curhan GC, et al. Arch Intern Med. 2004 Jul 26;164(14):1519-24. doi: 10.1001/archinte.164.14.1519. Arch Intern Med. 2004. PMID: 15277282 - A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine.
Bach PH, Berndt WO, Delzell E, Dubach U, Finn WF, Fox JM, Hess R, Michielsen P, Sandler DP, Trump B, Williams G. Bach PH, et al. Ren Fail. 1998 Nov;20(6):749-62. doi: 10.3109/08860229809045173. Ren Fail. 1998. PMID: 9834974 Review. - Nonnarcotic analgesics: prevalence and estimated economic impact of toxicities.
McGoldrick MD, Bailie GR. McGoldrick MD, et al. Ann Pharmacother. 1997 Feb;31(2):221-7. doi: 10.1177/106002809703100214. Ann Pharmacother. 1997. PMID: 9034424 Review.
Cited by
- NSAIDs, analgesics, antiplatelet drugs, and decline in renal function: a retrospective case-control study with SIDIAP database.
Bonet-Monné S, Urgell CV, Sáez MJP, Puertolás OC, Baena-Díez JM, Pascual J, Lago CO, Ruiz JR, Gonzalez BS, Pedrós RM. Bonet-Monné S, et al. BMC Pharmacol Toxicol. 2024 Aug 28;25(1):58. doi: 10.1186/s40360-024-00771-5. BMC Pharmacol Toxicol. 2024. PMID: 39198874 Free PMC article. - The Effect of Randomized Beta-Carotene Supplementation on CKD in Men.
Chewcharat A, Chewcharat P, Rexrode KM, Glynn RJ, Buring JE, Gaziano JM, Sesso HD. Chewcharat A, et al. Kidney Int Rep. 2024 Apr 4;9(6):1633-1640. doi: 10.1016/j.ekir.2024.04.001. eCollection 2024 Jun. Kidney Int Rep. 2024. PMID: 38899218 Free PMC article. - Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: results from the MIMIC-IV.
Meng Y, Lin Y, Zhang JW, Zou WL, Liu YM, Shen XG, Shen QQ, Wang MM, Shao LN, Feng HY, Zhu Y, Yu JT, Lin B, Zhu B. Meng Y, et al. Front Pharmacol. 2023 Nov 14;14:1292745. doi: 10.3389/fphar.2023.1292745. eCollection 2023. Front Pharmacol. 2023. PMID: 38034989 Free PMC article. - Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Taliercio JJ, Nakhoul G, Mehdi A, Yang W, Sha D, Schold JD, Kasner S, Weir M, Hassanein M, Navaneethan SD, Krishnan G, Kanthety R, Go AS, Deo R, Lora CM, Jaar BG, Chen TK, Chen J, He J, Rahman M; CRIC study Investigators. Taliercio JJ, et al. Kidney Med. 2022 Oct 4;4(11):100547. doi: 10.1016/j.xkme.2022.100547. eCollection 2022 Nov. Kidney Med. 2022. PMID: 36339663 Free PMC article. - Can NSAIDs be used safely for analgesia in patients with CKD?: PRO.
Barreto EF, Feely MA. Barreto EF, et al. Kidney360. 2020 Nov;1(11):1184-1188. doi: 10.34067/kid.0004582020. Kidney360. 2020. PMID: 34296195 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical